Letter: Pharmacovigilance of Tapinarof Adverse Effects Utilizing the Food and Drug Administration Adverse Event Reporting System Database.

HOME
>
論文・技術情報
>
Letter: Pharmacovigilance of Tapinarof Adverse Effects Utilizing the Food and Drug Administration Adverse Event Reporting System Database.

アブストラクト
ジャーナル名	Dermatitis : contact, atopic, occupational, drug
Pubmed追加日	2026/6/6
投稿者	Adler, Robert; Abraham, Alana; Gandhi, Isha; Feig, Jessica Lori
組織名	SUNY Downstate Department of Dermatology, Brooklyn, New York, USA.;University of Minnesota Twin Cities Medical School, Minneapolis, Minnesota, USA.;Dermatology Service, Veterans Affairs New York Harbor Healthcare System-Brooklyn;Campus, Brooklyn, New York, USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/42249781/